Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intelgenx Technologies Corp IGXT


Primary Symbol: T.IGX

Healthcare
IntelGenx Technologies Corp. is a Canada-based drug delivery company. The Company provides single-site, end-to-end contract development and manufacturing services of oral thin film and transdermal drug products for the pharmaceutical and animal health markets, spanning the entire drug development and commercial product cycle. The Company’s film technologies, including VersaFilm, DisinteQ... see more

Recent & Breaking News (TSX:IGX)

IntelGenx Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm(TM) Oral Film Product

Globe Newswire June 18, 2013

IntelGenx Announces FDA Acceptance of New Drug Application for Anti-Migraine VersaFilm(TM) Oral Film Product

Newsfile June 18, 2013

IntelGenx Reports Q1, 2013 Results and Provides Operational Update

Globe Newswire May 14, 2013

IntelGenx Reports Q1, 2013 Results and Provides Operational Update

Newsfile May 14, 2013

IntelGenx Technologies Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan

Newsfile May 9, 2013

IntelGenx Technologies Corp. Security Holders Approved the Amendment of the 2006 Stock Option Plan

Globe Newswire May 9, 2013

IntelGenx Grants Stock Options

Newsfile April 26, 2013

IntelGenx Grants Stock Options

Globe Newswire April 26, 2013

IntelGenx Secures Leadership Succession

Globe Newswire April 24, 2013

IntelGenx Secures Leadership Succession

Newsfile April 24, 2013

IntelGenx Submits New Drug Application for Anti-Migraine VersaFilm(TM)

Globe Newswire March 27, 2013

IntelGenx submits New Drug Application for Anti-Migraine VersaFilm(TM)

Newsfile March 27, 2013

IntelGenx Reports 2012 Annual Results and Provides Operational Update

Troy Schwensen March 18, 2013

IntelGenx Reports 2012 Annual Results and Provides Operational Update

Newsfile March 18, 2013

IntelGenx to Present at Roth Capital Partners 25th Annual Growth Stock Conference

Newsfile March 18, 2013

IntelGenx to Present at Roth Capital Partners 25th Annual Growth Stock Conference

Troy Schwensen March 18, 2013

Junior explorer jumps on potash resource projection

Sean Mason May 16, 2011

Junior exploration stock pops on copper/gold results

Sean Mason February 3, 2011